Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-060272

Adamas Pharmaceuticals Inc · ADMS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
MDV VII LP
10% Owner
MDV IX LP
10% Owner
Period of report
Jul 7, 2015
Accepted (ET)
Jul 9, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jul 7, 2015S25,737$27.5452D299,749IMDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Common StockF4,F3Jul 8, 2015S3,100$27.551D296,649IMDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Common StockF5holding———3,772,686IMDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common StockF5holding———265,150IMDV VII, L.P.
Common StockF5holding———6,043IMDV ENF VII (A), L.P.
Common StockF5holding———3,146IMDV ENF VII (B), L.P.
Common StockF5holding———25,661IMDV VII Leaders' Fund, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses